Literature DB >> 17986865

Diverse ways to control p27Kip1 function: miRNAs come into play.

Carlos le Sage1, Remco Nagel, Reuven Agami.   

Abstract

MicroRNAs (miRNAs) are small RNA molecules controlling messenger RNA (mRNA) and protein abundance. Since their discovery, research has been aimed at identifying the functions and target genes of miRNAs. A number of computer algorithms have been developed capable of predicting putative targets for any given miRNA. However, they might predict many false-positive targets and on top of that some true targets could be missed. This reflects the incomplete knowledge we still have concerning the rules governing true and effective miRNA-mRNA interactions. To experimentally identify miRNA-target genes, we have recently developed a genetic approach and employed it on p27(Kip1), a hapo-insufficient tumor suppressor and cell cycle inhibitor. Here we review the difficulties interpreting the data from available computer algorithms, and critically address the pros and cons of our genetic screening method. Additionally, we focus on the different ways in which p27 is managed, argue how miRNAs could be involved in the regulation of p27 in both normal and malignant conditions, and discuss possible use of this knowledge for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986865     DOI: 10.4161/cc.6.22.4900

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  25 in total

1.  XMRV accelerates cellular proliferation, transformational activity, and invasiveness of prostate cancer cells by downregulating p27(Kip1).

Authors:  Jui Pandhare-Dash; Chinmay K Mantri; Yuanying Gong; Zhenbang Chen; Chandravanu Dash
Journal:  Prostate       Date:  2011-09-19       Impact factor: 4.104

2.  Pumilio turns on microRNA function.

Authors:  Robinson Triboulet; Richard I Gregory
Journal:  Nat Cell Biol       Date:  2010-10       Impact factor: 28.824

3.  IKK-β/NF-κB p65 mediates p27(Kip1) protein degradation in arsenite response.

Authors:  Wei Guo; Jinyi Liu; Jinlong Jian; Jingxia Li; Yu Wan; Chuanshu Huang
Journal:  Biochem Biophys Res Commun       Date:  2014-04-18       Impact factor: 3.575

4.  Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation.

Authors:  Li Zou; Zhijie Ding; Partha Roy
Journal:  J Cell Physiol       Date:  2010-06       Impact factor: 6.384

5.  MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage.

Authors:  G Togliatto; A Trombetta; P Dentelli; A Rosso; M F Brizzi
Journal:  Diabetologia       Date:  2011-04-02       Impact factor: 10.122

6.  miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway.

Authors:  Dan-Dan Wang; Su-Jin Yang; Xiu Chen; Hong-Yu Shen; Long-Ji Luo; Xiao-Hui Zhang; Shan-Liang Zhong; Jian-Hua Zhao; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2016-10-04

7.  The alpha-fetoprotein (AFP) third domain: a search for AFP interaction sites of cell cycle proteins.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2016-07-22

8.  The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.

Authors:  Tong Sun; Qianben Wang; Steven Balk; Myles Brown; Gwo-Shu Mary Lee; Philip Kantoff
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

9.  miR-181a regulates cap-dependent translation of p27(kip1) mRNA in myeloid cells.

Authors:  Rafael Cuesta; Aida Martínez-Sánchez; Fátima Gebauer
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

Review 10.  Targeting prostate cancer based on signal transduction and cell cycle pathways.

Authors:  John T Lee; Brian D Lehmann; David M Terrian; William H Chappell; Franca Stivala; Massimo Libra; Alberto M Martelli; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2008-06-16       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.